Topics

Using Patient Preferences to Determine Noninferiority Margins in Trials.

07:00 EST 3rd December 2019 | BioPortfolio

Summary of "Using Patient Preferences to Determine Noninferiority Margins in Trials."

No Summary Available

Affiliation

Journal Details

This article was published in the following journal.

Name: JAMA
ISSN: 1538-3598
Pages: 2137-2138

Links

DeepDyve research library

PubMed Articles [18381 Associated PubMed Articles listed on BioPortfolio]

Using Patient Preferences to Determine Noninferiority Margins in Trials-Reply.

Exploring Patient Preferences for Adjunct-to-Insulin Therapy in Type 1 Diabetes.

While sodium-glucose cotransporter inhibitor (SGLTi) therapy has been evaluated in type 1 diabetes (T1D) trials, patient reaction to benefits and risks are unknown. Using established methodology, we e...

Determining Patient's Wishes and Preferences.

It is legally required to determine and respect patient preferences and wishes as much as possible under the circumstances given. This also applies to emergency medicine and intensive care, particular...

Optical coherence tomography in the assessment of cutaneous cancer margins of the face: an immediate ex vivo study.

The assessment of cutaneous cancer margins intra-operatively or in the immediate postoperative phase can guide the operator into achieving clearer margins. Achieving a clear (tumour-free) margins foll...

Early experiences with patient generated health data: health system and patient perspectives.

Although patient generated health data (PGHD) has stimulated excitement about its potential to increase patient engagement and to offer clinicians new insights into patient health status, we know litt...

Clinical Trials [5408 Associated Clinical Trials listed on BioPortfolio]

Patient Perceptions and Willingness to Enroll in Clinical Trials

The objective of our study is to determine which factors affect willingness to participate in gynecologic oncology clinical trials. Women with a diagnosis of gynecologic malignancy will be...

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Patients with a primary invasive melanoma are recommended to undergo excision of the primary lesion with a wide margin. There is evidence that less radical margins of excision may be just ...

Female Patient Preferences Regarding Physician Gender

This is a cross sectional survey study to describe female patient preferences when choosing their OB/GYN and other providers.

Sealing Defective Margins of Composite Restorations With Fluid Composite Resin Nanofiller Reinforced

the patient (n=60), with at least 3 composite resins with marginal defects , randomized into 3 groups A=Sealed with flow composite reinforced with nanofiller , B= Sealed with resin sealant...

Patient Priorities Care (PPC)

Patient Priorities Care aligns healthcare decision-making and care by all clinicians with patients' own health priorities. Patient Priorities Care involves not only the health outcome goal...

Medical and Biotech [MESH] Definitions

An approach or process of practicing oral health care that requires the judicious integration of systematic assessments of clinical relevant scientific evidence, relating to the patient's oral and medical condition and history, with the dentist's clinical expertise and the patient's treatment needs and preferences. (from J Am Dent Assoc 134: 689, 2003)

Providing an investigational therapy to a patient who is not eligible to receive that therapy in a clinical trial, but who has a serious or life-threatening illness for which other treatments are not available. Compassionate use trials allow patients to receive promising but not yet fully studied or approved therapies when no other treatment option exists. Also called expanded access trial.

Studies performed to evaluate the safety of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques in healthy subjects and to determine the safe dosage range (if appropriate). These tests also are used to determine pharmacologic and pharmacokinetic properties (toxicity, metabolism, absorption, elimination, and preferred route of administration). They involve a small number of persons and usually last about 1 year. This concept includes phase I studies conducted both in the U.S. and in other countries.

Works about a study where participants are assigned to a treatment, procedure, or intervention by methods that are not random. Non-randomized clinical trials are sometimes referred to as quasi-experimental clinical trials or non-equivalent control group designs.

Treatments which are undergoing clinical trials or for which there is insufficient evidence to determine their effects on health outcomes; coverage for such treatments is often denied by health insurers.

Quick Search


DeepDyve research library

Searches Linking to this Article